Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF TrialCirculation (New York, N.Y.), 2020-01, Vol.141 (2), p.90-99 [Peer Reviewed Journal]2020 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2019 The Authors. 2019 ;ISSN: 0009-7322 ;ISSN: 1524-4539 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.119.044138 ;PMID: 31736335Full text available |
|
2 |
Material Type: Article
|
Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER TrialCirculation (New York, N.Y.), 2022-10, Vol.146 (16), p.1210-1224 [Peer Reviewed Journal]2022 The Authors. 2022 ;ISSN: 0009-7322 ;ISSN: 1524-4539 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.122.061754 ;PMID: 36029465Full text available |
|
3 |
Material Type: Article
|
Effects of Serelaxin in Patients with Acute Heart FailureThe New England journal of medicine, 2019-08, Vol.381 (8), p.716-726 [Peer Reviewed Journal]Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1801291 ;PMID: 31433919Full text available |
|
4 |
Material Type: Article
|
Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection FractionJournal of the American College of Cardiology, 2023-02, Vol.81 (5), p.460-473 [Peer Reviewed Journal]2023 The Authors ;Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. ;ISSN: 0735-1097 ;ISSN: 1558-3597 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2022.11.006 ;PMID: 36526515Full text available |
|
5 |
Material Type: Article
|
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trialNature medicine, 2022-12, Vol.28 (12), p.2504-2511 [Peer Reviewed Journal]2022. The Author(s). ;The Author(s) 2022. corrected publication 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1078-8956 ;ISSN: 1546-170X ;EISSN: 1546-170X ;DOI: 10.1038/s41591-022-02102-9 ;PMID: 36522606Full text available |
|
6 |
Material Type: Article
|
Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicineEuropean heart journal, 2021-01, Vol.42 (2), p.152-161 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. ;Attribution - NonCommercial ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehaa736 ;PMID: 33099609Full text available |
|
7 |
Material Type: Article
|
Inflammation in Heart Failure: JACC State-of-the-Art ReviewJournal of the American College of Cardiology, 2020-03, Vol.75 (11), p.1324-1340 [Peer Reviewed Journal]Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2020.01.014 ;PMID: 32192660Full text available |
|
8 |
Material Type: Article
|
Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced TrialCirculation (New York, N.Y.), 2021-01, Vol.143 (4), p.326-336 [Peer Reviewed Journal]2020 The Authors. 2020 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.120.051783 ;PMID: 33081531Full text available |
|
9 |
Material Type: Article
|
Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 PandemicCirculation (New York, N.Y.), 2020-08, Vol.142 (5), p.429-436 [Peer Reviewed Journal]2020 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.120.048360 ;PMID: 32418446Full text available |
|
10 |
Material Type: Article
|
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesCirculation (New York, N.Y.), 2022-05, Vol.145 (18), p.e895-e1032 [Peer Reviewed Journal]ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/cir.0000000000001063 ;PMID: 35363499Full text available |
|
11 |
Material Type: Article
|
Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical ConsiderationsCirculation (New York, N.Y.), 2016-06, Vol.133 (24), p.2459-2502 [Peer Reviewed Journal]2016 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2016 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.116.022194 ;PMID: 27297342Full text available |
|
12 |
Material Type: Article
|
Empagliflozin in Heart Failure with a Preserved Ejection FractionThe New England journal of medicine, 2021-10, Vol.385 (16), p.1451-1461 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2107038 ;PMID: 34449189Full text available |
|
13 |
Material Type: Article
|
Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled studyEuropean heart journal, 2021-01, Vol.42 (2), p.178-188 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehaa898 ;PMID: 33245749Full text available |
|
14 |
Material Type: Article
|
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection FractionThe New England journal of medicine, 2022-09, Vol.387 (12), p.1089-1098 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2206286 ;PMID: 36027570Full text available |
|
15 |
Material Type: Article
|
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesJournal of the American College of Cardiology, 2022-05, Vol.79 (17), p.1757-1780 [Peer Reviewed Journal]Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved. ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2021.12.011 ;PMID: 35379504Full text available |
|
16 |
Material Type: Article
|
2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of AmericaJournal of the American College of Cardiology, 2016-09, Vol.68 (13), p.1476-1488 [Peer Reviewed Journal]Copyright Elsevier Limited Sep 27, 2016 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2016.05.011 ;PMID: 27216111Full text available |
|
17 |
Material Type: Article
|
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesJournal of the American College of Cardiology, 2022-05, Vol.79 (17), p.e263-e421 [Peer Reviewed Journal]Copyright © 2022 American Heart Association, Inc., the American College of Cardiology Foundation, and the Heart Failure Society of America. Published by Elsevier Inc. All rights reserved. ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2021.12.012 ;PMID: 35379503Full text available |
|
18 |
Material Type: Article
|
Cardiovascular and Renal Outcomes with Empagliflozin in Heart FailureThe New England journal of medicine, 2020-10, Vol.383 (15), p.1413-1424 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2022190 ;PMID: 32865377Full text available |
|
19 |
Material Type: Article
|
Age-Related Usage of GLP-1 Agonists in Obese Patients With Heart Failure and Preserved Ejection FractionJournal of the American College of Cardiology, 2024-04, Vol.83 (14), p.1348-1350 [Peer Reviewed Journal]EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2024.01.033 ;PMID: 38569765Full text available |
|
20 |
Material Type: Article
|
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved TrialCirculation (New York, N.Y.), 2021-10, Vol.144 (16), p.1284-1294 [Peer Reviewed Journal]Distributed under a Creative Commons Attribution 4.0 International License ;2021 The Authors. 2021 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.121.056824 ;PMID: 34459213Full text available |